GCB Newsletter Volume 3: Fall 2018

artistic rendering of a strand of DNA
GCB News

GCB Newsletter Volume 3: Fall 2018

Highlights to the current issue include:

  • Targeted epigenome editing as 'next generation drugs' for Parkinson's disease
  • New Genomic Medicine Collaboratory to serve as nexus for genetics, genomics community
  • Element Genomics acquired by global pharmaceuticals company
  • New Funding
  • Chris Nelson earns K99 grant
  • New undergrad course offers comprehensive overview of genome science tech
  • Tagliafierro receives grant to examine associations between aging, genetics, and Alzheimer's disease
  • Inaugural Summer Scholars Program Wrap Ups in End-of-Summer Poster Session
  • New GCB Collaboration Brings German Researchers, Scholars Stateside
  • Updates from the Cores
  • 2018 Fall SOM Core Facility Voucher Program

Read more

Related News

Gavilan Biodesign Company Logo

Bruce Donald's company featured at Duke Venture Day

Bruce Donald’s company, Gavilán Biodesign, was featured as one of eight Duke start-up investments at the first Duke Venture Day earlier this month.
view
Marchuk at 2019 spring faculty meeting

Marchuk awarded Research Mentoring Award for Basic Science

Doug Marchuk, Ph.D., Duke Professor of Molecular Genetics and Microbiology, was recognized at the 2019 Spring Faculty Meeting and awarded

view
group photo outside

GCB hosts first International Research Training Group Symposium

On Friday, April 26, GCB hosted the inaugural International Training Group (IRTG) Symposium.

view